Risk of colorectal neoplasia according to histologic disease activity in patients with inflammatory bowel disease and colonic post-inflammatory polyps.
Thomas WolfAyanna LewisLaurent BeaugerieMagali SvrcekJulien Kirchgesnernull nullPublished in: Alimentary pharmacology & therapeutics (2023)
After controlling for histologic activity, PIPs do not increase the risk of CRN in IBD patients. Histologic activity rather than PIPs should be considered in the risk assessment of CRN.
Keyphrases
- disease activity
- rheumatoid arthritis
- risk assessment
- end stage renal disease
- patients with inflammatory bowel disease
- systemic lupus erythematosus
- rheumatoid arthritis patients
- newly diagnosed
- ejection fraction
- chronic kidney disease
- ankylosing spondylitis
- peritoneal dialysis
- prognostic factors
- oxidative stress
- ulcerative colitis
- patient reported
- chronic rhinosinusitis